If your life is high-pressure, your body will burn through its natural glutathione stores much faster
An updated meta-analysis of nine randomised controlled trials (RCTs), including 8,920 patients with HF and T2D, reported a 13% reduction in major adverse cardiovascular events in the GLP-1 RA compared with placebo arm
This innovative medication mimics the GLP-1 hormone, effectively reducing appetite and promoting notable weight loss
Chaudhry et al., 2024)
Metabolic complications are common in patients suffering PCOS, including obesity, insulin resistance and type-2 diabetes, which severely compromise the clinical course of affected women
This thermogenic component is why retatrutide research outcomes in obesity models have exceeded those of tirzepatide in comparative literature, with 48-week weight reduction data reaching 24.2% for retatrutide against tirzepatides published benchmarks from SURPASS trials